/

Atrion Corporation

ATRI US

ATRI USAtrion Corporation

United States Composite

414.95

USD

-11.93

(-2.79%)

11.02EPS Dil.

37.64P/E

730.31MMarket Cap

2.10%Div. Yield

Next Earnings

May 6

Ex-Dividend Date

March 14

Dividend Date

March 29

Held by Insiders

22.90%

Held by Institutions

66.48%

Short % of Float

3.76%

YTD Yield

-35.80%

3Y Yield

-37.61%

5Y Yield

-54.33%

Capital Structure

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

ST Debt

- -

LT Borrowings

- -

LT Finance Leases

- -

Preferred Equity and Hybrid Capital

- -

Shares Outstanding

Market Capitalization

996

727

667

Working Capital

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

Total Current Assets

116

115

Cash, Cash Equivalents & STI

Accounts Receivable, Net

Inventories

Total Current Liabilities

Payables & Accruals

ST Debt

- -

Deferred Revenue

- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

2.68%

2.46%

-8.15%

Net Income, GAAP

-1.34%

-8.24%

-45.71%

Free Cash Flow

-3.66%

-12.91%

60.00%

Total Cash Common Dividend

11.85%

11.01%

- -

Total Equity

5.23%

2.98%

1.25%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

2021

165

2022

184

2023

169

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

2021

4.23

4.89

4.59

4.51

18.22

2022

4.72

5.21

4.95

4.70

19.59

2023

1.98

3.73

1.67

3.65

11.02

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

2021

1.75

1.74

1.95

7.39

2022

1.95

1.94

2.15

8.18

2023

2.15

2.20

8.69

Company Description

CEO: Mr. David A. Battat
Full Time Employees: 712
Sector: Healthcare
Industry: Medical Instruments & Supplies
Address: One Allentown Parkway Allen TX United States 75002-4211
IPO Date: Mar 18, 1980
Website: www.atrioncorp.com
Business: Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Company News

Yahoo
7 days ago
Favourable Signals For Atrion: Numerous Insiders Acquired Stock
Yahoo
10 days ago
Trucking research firm touts renewable diesel fuel over EV transition
Yahoo
a month ago
Some Investors May Be Worried About Atrion's (NASDAQ:ATRI) Returns On Capital

Company Description

CEO: Mr. David A. Battat
Full Time Employees: 712
Sector: Healthcare
Industry: Medical Instruments & Supplies
Address: One Allentown Parkway Allen TX United States 75002-4211
IPO Date: Mar 18, 1980
Website: www.atrioncorp.com
Business: Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.